James A. Johnson's most recent trade in Athira Pharma Inc was a trade of 20,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 24, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Athira Pharma Inc | James A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
Athira Pharma Inc | James A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
Athira Pharma Inc | James A. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 29 Mar 2023 | 5,000 | 5,000 | - | 2.4 | 12,000 | Common Stock |
Athira Pharma Inc | James A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 13,871 | 13,871 | - | - | Stock Option (Right to Buy) | |
Athira Pharma Inc | James A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 13,871 | 13,871 | - | - | Stock Option (Right to Buy) |